DE LUCA, Giuseppe
 Distribuzione geografica
Continente #
AS - Asia 2.075
NA - Nord America 1.444
SA - Sud America 908
EU - Europa 726
AF - Africa 58
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.214
Nazione #
US - Stati Uniti d'America 1.365
SG - Singapore 1.085
BR - Brasile 791
HK - Hong Kong 446
IT - Italia 271
CN - Cina 257
VN - Vietnam 103
RU - Federazione Russa 98
DE - Germania 82
IE - Irlanda 64
GB - Regno Unito 43
IN - India 43
AR - Argentina 39
CA - Canada 38
AT - Austria 37
MX - Messico 29
BD - Bangladesh 27
EC - Ecuador 25
ZA - Sudafrica 25
FI - Finlandia 23
SE - Svezia 19
IQ - Iraq 17
NL - Olanda 17
FR - Francia 15
PK - Pakistan 14
UA - Ucraina 14
CL - Cile 13
PL - Polonia 13
TR - Turchia 13
UZ - Uzbekistan 12
CO - Colombia 10
VE - Venezuela 10
ES - Italia 9
PE - Perù 9
CI - Costa d'Avorio 8
ID - Indonesia 8
JO - Giordania 8
JP - Giappone 8
AZ - Azerbaigian 7
MA - Marocco 7
KE - Kenya 6
LT - Lituania 5
UY - Uruguay 5
EG - Egitto 4
IL - Israele 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
TN - Tunisia 3
AM - Armenia 2
AU - Australia 2
BE - Belgio 2
BH - Bahrain 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
DZ - Algeria 2
GR - Grecia 2
IR - Iran 2
JM - Giamaica 2
KG - Kirghizistan 2
LB - Libano 2
MY - Malesia 2
PA - Panama 2
PT - Portogallo 2
SN - Senegal 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
EE - Estonia 1
HN - Honduras 1
KZ - Kazakistan 1
LV - Lettonia 1
MT - Malta 1
NP - Nepal 1
PH - Filippine 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.214
Città #
Hong Kong 443
Singapore 393
Ashburn 348
Dallas 311
Los Angeles 95
Beijing 82
Dublin 63
Messina 56
São Paulo 50
Moscow 47
Buffalo 44
Ho Chi Minh City 40
Catania 39
New York 39
Redondo Beach 39
Paternò 30
Rio de Janeiro 30
Frankfurt am Main 28
Hanoi 27
Belo Horizonte 26
Munich 26
Hyderabad 24
Vienna 23
Boardman 21
The Dalles 21
Turin 18
Brooklyn 16
Johannesburg 16
Nuremberg 16
Porto Alegre 16
Mexico City 15
Santa Clara 15
Amsterdam 13
Montreal 13
Tianjin 13
Chandler 11
Curitiba 11
San Francisco 11
Warsaw 11
Dhaka 10
Guayaquil 10
London 10
Ribeirão Preto 10
Tashkent 10
Caxias do Sul 9
Chennai 9
Helsinki 9
Manchester 9
Quito 9
Abidjan 8
Amman 8
Atlanta 8
Boston 8
Campinas 8
Chicago 8
Milan 8
Phoenix 8
Prineville 8
Baku 7
Lappeenranta 7
Santo André 7
Seattle 7
Stockholm 7
Tokyo 7
Ankara 6
Biên Hòa 6
Florianópolis 6
Franca 6
Goiânia 6
Guarulhos 6
Maceió 6
Sumaré 6
Toronto 6
Washington 6
Baghdad 5
Denver 5
Feira de Santana 5
Fortaleza 5
Lima 5
Nairobi 5
Nyköping 5
Springfield 5
São José do Rio Preto 5
Vancouver 5
Barbacena 4
Betim 4
Brasília 4
Charlotte 4
Contagem 4
Fiumefreddo di Sicilia 4
Fort Worth 4
Gravataí 4
Guangzhou 4
Houston 4
Jakarta 4
Manaus 4
Orem 4
Ottawa 4
Palhoça 4
Poplar 4
Totale 2.923
Nome #
Short and long-term benefits of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials 168
The Inconclusive Results of the Studies on Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease: An Area of Darkness 130
Analysis of beta 1 and beta 2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy 108
Immature platelet fraction and the extent of coronary artery disease: a single centre study 98
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease 97
Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials 72
Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols 64
Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study 58
A meta-analytic overview of thrombectomy during primary angioplasty 57
Impact of Diabetes on Long-Term Outcome After Primary Angioplasty: Insights from the DESERT cooperation 55
Characteristics of patients with recurrent acute myocardial infarction after MINOCA 52
Diabetes, glucose control and mean platelet volume: a single-centre cohort study 50
Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review 50
The role of statins in the prevention of contrast induced nephropathy: a meta-analysis of 8 randomized trials 48
Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials 48
Relationship between changes in platelet reactivity and ischemic events following percutaneous coronary intervention: a meta-regression analysis of 30 randomized trials 47
Impact of age on pre-procedural TIMI flow in STEMI patients undergoing primary percutaneous coronary intervention 47
Long-term results of the randomized comparison of everolimus-eluting stents and sirolimus-eluting stent in patients with ST elevation myocardial infarction (RACES-MI trial) 47
Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials 46
Meta-analysis of 14 trials comparing bypass grafting vs drug-eluting stents in diabetic patients with multivessel coronary artery disease 46
Platelet GP IIb-IIIa receptor antagonists in primary angioplasty: Back to the future 46
Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor 46
Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial 45
ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome 45
Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors 44
Preinfarction angina does not affect infarct size in STEMI patients undergoing primary angioplasty 44
Bivalirudin Versus Unfractionated Heparin in Acute Coronary Syndromes: An Updated Meta-analysis of Randomized Trials 44
Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience 44
Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients with Acute Coronary Syndromes Undergoing Early Percutaneous Revascularization 44
Antiplatelet Strategies for Older Patients with Acute Coronary Syndromes: Finding Directions in a Low-Evidence Field 44
Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT Cooperation) 44
Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study 43
Impact of age on long-term outcome after primary angioplasty with bare-metal or drug-eluting stent (from the DESERT cooperation) 43
Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor 43
Impact of hypertension on distal embolization, myocardial perfusion, and mortality in patients with ST segment elevation myocardial infarction undergoing primary angioplasty 42
Pre-diabetes and the risk of contrast induced nephropathy in patients undergoing coronary angiography or percutaneous intervention 42
Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry 42
Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials 41
Eosinophils count and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions 41
Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease: Results from a Large Cohort Study 41
Mean platelet volume and the risk of periprocedural myocardial infarction in patients undergoing coronary angioplasty 41
Gender-related differences in outcome after BMS or DES implantation in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: insights from the DESERT cooperation 41
Immature platelet fraction and the extent of coronary artery disease: A single centre study 41
Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study 41
ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease' 41
Comprehensive meta-analysis of radial vs femoral approach in primary angioplasty for STEMI 41
"Meta-Analysis of Ablation of Atrial Flutter and Supraventricular Tachycardia" 41
Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients 40
Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis 40
Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI 40
Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers 40
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation 40
Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 40
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor: Reply 40
Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials 40
Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study 40
An unusual case of ECG ST-segment elevation 39
Elevated Homocysteine and the Risk of Contrast-Induced Nephropathy: A Cohort Study 39
Relation of Gender to Infarct Size in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Angioplasty 39
Impact of renal function on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study 38
Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials 38
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 38
Advances in antithrombotic therapy as adjunct to reperfusion therapies for ST-segment elevation myocardial infarction 38
Switching from Clopidogrel to Prasugrel in patients undergoing PCI: A meta-analytic overview 38
Impact of red blood cells count and high density lipoproteins with the prevalence and extent of coronary artery disease 38
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale 37
Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy 36
Switching from high-dose clopidogrel to prasugrel in ACS patients undergoing PCI: a single-center experience 36
Adjunctive antithrombotic therapy during Primary PCI 36
Age-Related Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry 36
Impact of multivessel disease on infarct size among STEMI patients undergoing primary angioplasty 36
Vitamin D levels condition the outcome benefits of renin-angiotensin system inhibitors (RASI) among patients undergoing percutaneous coronary intervention 36
Impact of hypertension on clinical outcome in STEMI patients undergoing primary angioplasty with BMS or DES: insights from the DESERT cooperation 36
Optimal Duration of Dual Antiplatelet Therapy After DES Implantation: A Meta-Analysis of 11 Randomized Trials 36
Meta-analysis comparing efficacy and safety of first generation drug-eluting stents to bare-metal stents in patients with diabetes mellitus undergoing primary percutaneous coronary intervention 36
Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient- level meta-analysis of randomized trials 36
Everolimus-eluting stent versus Sirolimus-eluting stent for prognostic significance 36
Time-related changes in neointimal tissue coverage of a novel Sirolimus eluting stent: Serial observations with optical coherence tomography 36
Aging, impaired myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty 35
Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials 35
Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease 35
Absence of seasonal variation in myocardial perfusion, enzymatic infarct size, and mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty 35
Platelet glycoprotein IIIa Leu33Pro gene polymorphism and coronary artery disease: A meta-analysis of cohort studies 35
Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT–FFR trial 35
Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study 34
No-reflow reversibility: a study based on serial assessment of multiple biomarkers 34
Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: A single-centre study 34
Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes 34
Relationship Between Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease 33
Impact of diabetes on uric acid and its relationship with the extent of coronary artery disease and platelet aggregation: a single-centre cohort study 33
Impact of COVID-19 pandemic on mechanical reperfusion for patients with STEMI 33
Platelet distribution width and the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention 33
Drug-eluting stents in patients with anterior STEMI undergoing primary angioplasty: a substudy of the DESERT cooperation 33
Evaluation of intracoronary adenosine to prevent periprocedural myonecrosis in elective percutaneous coronary intervention (from the PREVENT-ICARUS Trial) 32
Sirolimus-eluting versus paclitaxel-eluting stent in primary angioplasty: a pooled patient-level meta-analysis of randomized trials 31
Glycosylated hemoglobin and coronary artery disease in patients without diabetes mellitus 31
Time-to-treatment and infarct size in STEMI patients undergoing primary angioplasty 30
Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease 30
Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study 29
Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapy 28
Totale 4.439
Categoria #
all - tutte 33.545
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.545


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 1 0 0 0 1 1 1
2021/202212 0 0 0 0 1 2 1 0 1 3 1 3
2022/2023708 2 3 1 4 4 5 3 4 11 473 198 0
2023/2024389 2 31 68 22 26 34 38 4 1 34 8 121
2024/20252.566 21 27 28 176 142 106 90 338 621 152 321 544
2025/20262.118 310 478 454 327 493 56 0 0 0 0 0 0
Totale 5.809